Publication | Closed Access

Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro

Breast OncologyMedicineClassical Cytotoxic AgentsBreast CancerPharmacotherapyTumor TargetingAnti-cancer AgentFluvastatin EnhancementPharmacologyRadiation OncologyTumor MicroenvironmentDrug Discovery